このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Lifecare マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Joacim Holter

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	3.8yrs
CEOの所有権	0.2%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	3.7yrs

経営陣の近況

Recent updates

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Apr 30

CEO（最高経営責任者

Joacim Holter

3.8yrs

在職期間

Mr. Joacim Holter serves as Head of Investor Relation at Lifecare AS. He has been the Chief Executive Officer at Lifecare AS since September 06, 2020 and had been a Director since 2011. He was the Chairman...

取締役

名称	ポジション	在職期間	報酬	所有権
Bo Petersson	Independent Director	3.7yrs	データなし	データなし
Hans Hekland	Independent Director	3.2yrs	データなし	0.12% NOK 429.5k
Lutz Heinemann	Member of Scientific Advisory Board & Independent Director	3.7yrs	データなし	データなし
David Klonoff	Chairman of Scientific Advisory Board	no data	データなし	データなし
Morten Krohnstad	Independent Chairman of the Board	3.7yrs	データなし	データなし
Kåre Birkeland	Member of Scientific Advisory Board	no data	データなし	データなし
Michael Huth	Member of Scientific Advisory Board	4.5yrs	データなし	データなし
Trine Teigland	Independent Director	4.1yrs	データなし	データなし
Tony James	Member of Scientific Advisory Board	less than a year	データなし	データなし

3.7yrs

平均在職期間

経験豊富なボード: LIFEの取締役会は経験豊富であると考えられます ( 3.6年の平均在任期間)。

Lifecare マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

No independent directors

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Recent updates

New major risk - Shareholder dilution

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 90 million.

Lifecare AS Files Application for a New Patent

Lifecare AS Announces Successful Pilot Production

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 90 million.

Full year 2023 earnings released: kr0.29 loss per share (vs kr0.17 loss in FY 2022)

Full year 2023 earnings released: kr0.27 loss per share (vs kr0.15 loss in FY 2022)

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

New minor risk - Shareholder dilution

Lifecare AS Announces the Norwegian Food Safety Authority Receives Approval to Start LFC-SEN-002

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 42.5 million.

New major risk - Financial position

Lifecare AS to Report Q1, 2023 Results on May 10, 2023

No independent directors

Lifecare AS Announces Interim Data Analysis of the First In-Human Study

Lifecare as Initiates Clinical Studies of the Smallest Glucose Sensor in the Worldr People Diagnosed with Diabeabetes

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Lifecare AS (OB:LIFE) signed a term sheet agreement to acquire PFÜTZNER Science & Health Institute GmbH for €1.18 million.

Lifecare AS (OB:LIFE) acquired Cantimed Ug (Haftungsbeschrsnkt) from NanoScale Systems Gmbh for €0.65 million.

Chairman of the Board Christian Hysing-Dahl has left the company

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Lifecare AS to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day high: kr6.40

New 90-day low: kr3.62

Lifecare AS Announces Board Appointments

New 90-day low: kr4.00

Lifecare Receives EUR 3.9 Million from the EU Commission for Development of Bionic Invisible Pancreas to Forgetdiabetes

New 90-day high: kr7.00

Chief Scientific Officer recently sold kr270k worth of stock

Lifecare Appoints Joacim Holter as CEO

CEO（最高経営責任者

在職期間

取締役

平均在職期間

マネジメント基準チェック /14